All In Biotech

Drug Trial Radar · NCT05061732

Helicobacter Pylori Eradication and Follow-up

Helicobacter Pylori Eradication and Follow-up in Zhongshan Hospital

Last checked: Nov 19, 2026Latest source record: Sep 30, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

4,447

Planned (sponsor's estimate)

Start

Sep 30, 2021

Primary completion

Jun 30, 2026

Study completion Jun 30, 2026

Sponsor

Lead sponsor
Shanghai Zhongshan HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 30, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized controlled clinical trial will estimate the eradication efficacy of different therapy for Helicobacter pylori treatment. The completion of this trial will expand new therapy for the treatment of Helicobacter pylori, which can not only ensure clinical efficacy, but also reduce the use of antibiotics.

Conditions

  • Helicobacter Pylori Infection

Interventions

  • RabeprazoleDrug

    20mg bid

  • Bismuth potassium citrateDrug

    0.6g bid

  • MetronidazoleDrug

    0.4g qid

  • ClarithromycinDrug

    0.5g bid

  • LevofloxacinDrug

    0.5g qd

  • AmoxicillinDrug

    1g tid

  • MetronidazoleDrug

    0.4g tid

  • DoxycyclineDrug

    0.1g bid

  • TetracyclineDrug

    0.5g qid

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Eradication rate of Helicobacter pyloriTime frame: 6 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Zhongshan Hospital, Fudan University

    Shanghai, Shanghai Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.